FOR THE LATEST DEVELOPING NEWS
Click Here
Hospitals Enrolling COVID-19 Severe-to-Critical
Investment Community Webcast on Thursday, November 5
CytoDyn on CNBC as leading performer among COVID-19 treatment stocks
Dr. Seethamraju’s Presentation at Special isirv-AVG Virtual Conference
Manuscript Accepted by Infectious Diseases Society of America
Leronlimab for TNBC
Proactive Investors Interview on November 23
Leronlimab’s Mechanism of Action in COVID-19 Published
